| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.12 | 0.6 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.035 | 0.6 |